Berasain C, Betés M, Panizo A, Ruiz J, Herrero J I, Civeira M P, Prieto J
Department of Medicine and Liver Unit, Medical School and Clínica Universitaria, University of Navarra, Pamplona, Spain.
Gut. 2000 Sep;47(3):429-35. doi: 10.1136/gut.47.3.429.
The histopathological spectrum and role of hepatitis viruses in cases of hypertransaminasaemia of unknown aetiology have not been correctly analysed in a sufficiently large number of patients.
We studied 1075 consecutive patients referred for liver biopsy because of elevation of alanine aminotransferase (ALT) levels for more than six months. From this population we selected those cases in whom the aetiology could not be defined from clinical, biochemical, and serological data obtained before biopsy. In these patients liver biopsies were reviewed, and hepatitis B virus (HBV)-DNA and hepatitis C virus (HCV)-RNA were assayed in serum by polymerase chain reaction (PCR). Serum hepatitis G virus (HGV)-RNA was determined by PCR in 74 patients.
Of 1075 patients studied, the cause of the increased serum ALT levels remained elusive after appropriate testing in 109 patients (10.1%). Liver biopsies from these patients showed non-specific changes in 32.7% of cases, non-alcoholic steatohepatitis (NASH) in 15.8%, and chronic hepatitis or cirrhosis in 51.5%. HBV-DNA and/or HCV-RNA was detected more frequently in cryptogenic liver disease than in healthy blood donors (26.7% v 3.4%; p<0.001). HGV-RNA was found in only one patient. The proportion of cases with detectable HBV-DNA or HCV-RNA was 14.3% in patients with non-specific changes or NASH, 30.7% in patients with chronic hepatitis, and 61.5% in patients with cirrhosis. Cirrhosis was found more frequently in patients with positive HBV-DNA and/or HCV-RNA in serum than in those who tested negatively (p=0.005).
In our series, patients in whom biochemical and serological data did not determine the aetiology of the disease represented 10% of all cases referred for liver biopsy for persistent elevation of serum transaminases. Approximately 50% of patients had chronic hepatitis or cirrhosis and the remainder had NASH or non-specific changes. Occult viral infections were found in a high proportion of cases in the first group and in a low percentage of patients in the second.
在大量患者中,尚未对病因不明的高转氨酶血症病例中肝炎病毒的组织病理学谱及其作用进行正确分析。
我们研究了1075例因丙氨酸转氨酶(ALT)水平升高超过6个月而接受肝活检的连续患者。从该人群中,我们选择了那些根据活检前获得的临床、生化和血清学数据无法确定病因的病例。对这些患者的肝活检进行复查,并通过聚合酶链反应(PCR)检测血清中的乙型肝炎病毒(HBV)-DNA和丙型肝炎病毒(HCV)-RNA。在74例患者中通过PCR测定血清庚型肝炎病毒(HGV)-RNA。
在研究的1075例患者中,经过适当检测后,109例患者(10.1%)血清ALT水平升高的原因仍不明确。这些患者的肝活检显示,32.7%的病例有非特异性改变,15.8%为非酒精性脂肪性肝炎(NASH),51.5%为慢性肝炎或肝硬化。隐匿性肝病患者中检测到HBV-DNA和/或HCV-RNA的频率高于健康献血者(26.7%对3.4%;p<0.001)。仅在1例患者中发现HGV-RNA。在有非特异性改变或NASH的患者中,可检测到HBV-DNA或HCV-RNA的病例比例为14.3%,慢性肝炎患者中为30.7%,肝硬化患者中为61.5%。血清中HBV-DNA和/或HCV-RNA阳性的患者中肝硬化的发生率高于检测阴性的患者(p=0.005)。
在我们的系列研究中,生化和血清学数据无法确定疾病病因的患者占因血清转氨酶持续升高而接受肝活检的所有病例的10%。约50%的患者患有慢性肝炎或肝硬化,其余患者患有NASH或非特异性改变。在第一组中,高比例的病例发现有隐匿性病毒感染,而在第二组中,此类患者的比例较低。